No abstract available
Keywords:
chemotherapy; chronic lymphocytic leukaemia; clinical trial; minimal residual disease; monoclonal antibody.
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bendamustine Hydrochloride / administration & dosage
-
Bendamustine Hydrochloride / therapeutic use
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / therapeutic use
-
Female
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Male
-
Middle Aged
-
Treatment Outcome
-
Vidarabine / administration & dosage
-
Vidarabine / analogs & derivatives
-
Vidarabine / therapeutic use
Substances
-
Antibodies, Monoclonal, Humanized
-
Cyclophosphamide
-
Bendamustine Hydrochloride
-
Vidarabine
-
ofatumumab
-
fludarabine